Showing results (1601-1610 of 1,681) with videos related to

Sort By:
Pageof 169
Trials|October 4, 2017
General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trialJanine Bates, Nick A Francis, Patrick White, et al.
Bjpsych Open|December 15, 2025
Economic evaluation of digitally supported therapy for people with psychosis who hear distressing voices: the AVATAR2 trialPaul McCrone, Evdoxia Gkaintatzi, Thomas Ward, et al.
Plos One|January 22, 2021
Derivation and validation of a clinical severity score for acutely ill adults with suspected COVID-19: The PRIEST observational cohort studySteve Goodacre, Ben Thomas, Laura Sutton, et al.
Cell Death and Differentiation|October 25, 2019
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteinsLeah Fitzsimmons, Rachel Cartlidge, Catherine Chang, et al.
Targeted Oncology|November 9, 2020
Developing Symptom Lists for People with Cancer Treated with Targeted TherapiesSamantha C Sodergren, Sally J Wheelwright, Deborah Fitzsimmons, et al.
EULAR Rheumatology Open|August 1, 2026
Validation of an AI-based automated Knee Inflammation MRI Scoring System for assessing bone marrow lesionsRory Gilliland, Steel McDonald, Stephanie Wichuk, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|October 25, 2016
Large scale accelerator production of 225Ac: Effective cross sections for 78-192MeV protons incident on 232Th targetsJ R Griswold, D G Medvedev, J W Engle, et al.
Research in Social & Administrative Pharmacy : RSAP|June 28, 2017
Medication understanding among patients living with multiple chronic conditions: Implications for patient-reported measures of adherenceR J Fredericksen, L Gibbons, S Brown, et al.
Genes & Development|January 8, 2014
Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53Gemma L Kelly, Stephanie Grabow, Stefan P Glaser, et al.
BMJ Open|May 27, 2026
Reducing the impact of diabetic foot ulcers (REDUCE): study protocol for an effectiveness and cost-effectiveness randomised controlled trial with embedded process evaluationNatasha Mitchell, Kavita Vedhara, Kieran Ayling, et al.
Pageof 169